In September, 2024, WHO warned of the serious threat of antimicrobial resistance in Ukraine as Russia's invasion continues. Ed Holt reports.

We read with concern the hepatotoxicity results of the SimpliciTB trial. 11 (7%) of 150 patients treated with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) had serious liver toxicity (one patient died of drug-induced liver injury), co...

We read with concern the hepatotoxicity results of the SimpliciTB trial. 11 (7%) of 150 patients treated with bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) had serious liver toxicity (one patient died of drug-induced liver injury), co...

William Burman and colleagues suggest that the hepatotoxicity of the bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) regimen observed in the SimpliciTB trial1 was predictable from the liver-related treatment emergent adverse events repo...

William Burman and colleagues suggest that the hepatotoxicity of the bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) regimen observed in the SimpliciTB trial1 was predictable from the liver-related treatment emergent adverse events repo...

Strongyloidiasis is a soil-transmitted helminthiasis that is estimated to affect 300–600 million people across Asia, Africa, South and central America, and the Pacific. This neglected parasitic disease is most known for its ability to persist as a life...

Strongyloidiasis is a soil-transmitted helminthiasis that is estimated to affect 300–600 million people across Asia, Africa, South and central America, and the Pacific. This neglected parasitic disease is most known for its ability to persist as a life...

Donald McNeil Jr started working at The New York Times as a copyboy in 1976. He eventually became their science correspondent and held that position for 25 years before retiring in 2021. For a quarter century, McNeil reported on global health issues an...

Donald McNeil Jr started working at The New York Times as a copyboy in 1976. He eventually became their science correspondent and held that position for 25 years before retiring in 2021. For a quarter century, McNeil reported on global health issues an...

Dengue is a rapidly escalating global health issue, driven by intertwined factors such as four non-mutually cross-protective dengue virus (DENV) serotypes, deforestation, overpopulation, urbanisation, global connectivity, insecticide-resistant mosquito...

Dengue is a rapidly escalating global health issue, driven by intertwined factors such as four non-mutually cross-protective dengue virus (DENV) serotypes, deforestation, overpopulation, urbanisation, global connectivity, insecticide-resistant mosquito...

Our study indicates that case surveillance skews the perceived epidemiological footprint of DENV. We reveal a more complex and intricate pattern of serotype distribution in inapparent infections. The substantial differences in infection outcomes by ser...

Our study indicates that case surveillance skews the perceived epidemiological footprint of DENV. We reveal a more complex and intricate pattern of serotype distribution in inapparent infections. The substantial differences in infection outcomes by ser...

Interference between passive immunity and vaccine response is clinically significant and might affect the implementation of next-generation CSP-based vaccines for young infants and mothers as well as passive immunisation with human monoclonal antibodies.

Boosting mRNA-immunised adults with ARCT-2301 induced superior immunogenicity compared with Comirnaty BA.4-5 against both Wuhan-Hu-1 and omicron BA.4/5 variant COVID-19, and elicited a higher response against omicron XBB.1.5. Both vaccines had similar ...

In 2021, RTS,S/AS01 became the first human parasite vaccine approved by WHO for the prevention of Plasmodium falciparum malaria in children from 5 months of age living in regions with moderate to high transmission.1 The vaccine consists of the NANP-rep...